摘要
目的探讨微卡治疗对慢性阻塞性肺疾病(COPD)急性发作的疗效。方法56例COPD患者分为微卡治疗组及正常对照组,微卡治疗组,每周注射微卡22.5 ug,连续注射20周。其它治疗(对症,支持治疗)两组相同。结果微卡组急性发作频率较对照组明显减轻,P<0.05,临床检查中,痰菌控制也较对照组好。结论微卡能调节免疫功能,在COPD的治疗及预防中,有较好的疗效,值得临床推广使用。
Objective To explore treatment effect of vaccae on COPD of its frequency and change of clinical situation in acute stage. Methods A totalof 56 COPD patients were divided into two groups ： the vaccae group and the control group. The vaccae group was given 22. 5 ug once a week with muscular injection for a consecutive 20 weeks. Both groups were given regular symptom treatment and sup- portive therapy. Results The frequency in acute stage in the vaccae group was obviously less than that in the control group ： P 〈 0.05. The former group also showed a better control on original bacteria in sputum. Conclusion Vaccae can serve to adjust the immunity function. It has a favorable treatment effect in the prevention and treatment of COPD patients. It is worthy of being recommended for a wider use in clinical practice.
出处
《临床肺科杂志》
2008年第8期965-966,共2页
Journal of Clinical Pulmonary Medicine
